We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

UTZ:NYSEUtz Brands Inc Analysis

Data as of 2026-05-28 - not real-time

$7.45

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Utz Brands is trading well below its long‑term average price, signaling a bearish technical backdrop. The 20‑day and 50‑day moving averages sit above the current price, reinforcing the downside bias. Momentum indicators hover around the midpoint, indicating neutral pressure rather than strong oversold conditions. A modest bullish MACD histogram suggests a potential short‑term reversal, but the signal remains tentative. Recent earnings surprised on the upside, delivering earnings per share above analyst expectations, while top‑line growth was modest. The company maintained its full‑year guidance despite the slight revenue miss, underscoring management confidence.
Valuation metrics point to a deep discount relative to intrinsic estimates, with the discounted cash flow model implying a price far lower than today’s market level. The price‑to‑book ratio sits below parity, and the forward price‑to‑earnings multiple is modest, supporting a value case. A dividend yield that ranks among the higher tier in the consumer defensive space, coupled with a comfortable payout ratio, suggests a sustainable dividend. Balance sheet pressures are evident, with debt levels high relative to equity, yet operating cash flow remains positive. Volatility is elevated, reflecting a wide price swing range, while beta remains low, indicating limited correlation with broader market moves. Given the blend of undervaluation, dividend appeal, and manageable risks, the stock presents an attractive entry point for investors with a medium to long horizon.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • earnings beat with modest revenue growth
  • technical indicators showing bearish bias
  • high dividend yield supporting income focus

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • significant valuation discount to intrinsic value
  • sustainable dividend with low payout ratio
  • stable operating cash flow despite debt load

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • defensive consumer sector positioning
  • brand portfolio offering growth upside
  • ongoing dividend income and potential price appreciation

Key Metrics & Analysis

Financial Health

Revenue Growth2.60%
Profit Margin-0.58%
P/E Ratio8.9
ROE-1.16%
ROA0.27%
Debt/Equity77.64
P/B Ratio0.9
Op. Cash Flow$120.2M
Free Cash Flow$71.3M

Technical Analysis

TrendBearish
RSI47.2
Support$6.92
Resistance$8.68
MA 20$7.55
MA 50$7.61
MA 200$10.10
MACDBullish
VolumeStable
Fear & Greed Index92.34

Valuation

Fair Value$0.95
Target Price$12.14
Upside/Downside62.90%
GradeUndervalued
TypeValue
Dividend Yield3.37%

Risk Assessment

Beta0.56
Volatility49.87%
Sector RiskLow
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.